Ashland, MA, USA – MatTek Corporation is proud to announce that its tissue production facility in Bratislava, Slovakia has obtained ISO 9001:2008 accreditation from the Slovak Association for Quality and Management Systems, Ltd. (SKQS).
This certification is an important step in assuring that customers continue to receive the very best quality and service from MatTek. This achievement follows the recent ECVAM validation and OECD (TG 492) acceptance of the EpiOcular Eye Irritation Test (EIT), which marked the company’s third regulatory approved assay. The certified site includes 350 m2 of production laboratories, a training laboratory and an R&D unit.
“The ISO:9001-2008 certification of IVLSL is a great achievement and demonstrates our high standards set for the production of in vitro 3D tissue models, both for toxicology and pharmacology use,” said Dr. Helena Kandarova, Executive Director of MatTek IVLSL. “The certification does not only apply to the production processes, but also to the scientific services provided to our customers, including training and proof of concept studies.”
The ISO 9001:2008 quality management standard was developed and published by the International Organization for Standardization (ISO) and establishes an effective quality management program, focusing on customer satisfaction, and the establishment of processes for continuous improvement.
MatTek Corporation is a global leader in the production of the highest quality in vitro human tissue models for safety and efficacy testing for the chemical, cosmetic, household product, and pharmaceutical industries. For over 25 years, MatTek has established a reputation for the consistent manufacture of quality in vitro human tissue models, and the continuous development of innovative tissue engineering technologies and assays. This latest accomplishment further demonstrates the commitment to continue its history of outstanding products and services into the future.
Available for Download: MatTek IVLSL ISO Certificate
